The SHIELD project and the EARLYSCAN Cluster were presented during the Early Screening & Hereditary Cancer Awareness Network session at Athens Digital Health Week 🧬
👉 Learn more and read our latest news:
https://missionshield.eu/shield-at-athens-digital-health-week-advancing-cluster-collaboration-in-hereditary-cancer/
#DigitalHealth #HereditaryCancer #EarlyScreening

We’re proud to share the launch of EARLYSCAN, a new European cluster uniting three Horizon Europe projects: SHIELD, DISARM, and PREDI-LYNCH, under the EU Mission on Cancer.

EARLYSCAN brings projects together to align clinical pathways, data standards, and implementation practices — moving from isolated innovation to coordinated, real-world impact.

Read the press release: https://martel-innovate.prowly.com/445670-new-european-project-cluster-earlyscan-launched-to-advance-early-detection-of-heritable-cancers?preview=true

#EARLYSCAN #SHIELD #EarlyDetection #HereditaryCancer

Kyobo Life Insurance has secured exclusive rights for a new rider covering hereditary female cancer gene and NGS panel tests, marking an industry first in South Korea's insurance sector and expanding personalized cancer care options for women.
#YonhapInfomax #KyoboLifeInsurance #HereditaryCancer #GeneTesting #NGSPanel #ExclusiveRights #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90190

💥Are we still social on social media?💥 Hannah Ditchfield and I say yes! We explored #TikTok content about #hereditarycancer and found 3 types of identity work 👇. Part of @leverhulmetrust -funded Previvorship (https://sites.google.com/sheffield.ac.uk/previvorship), out in Social Media+Society: https://journals.sagepub.com/doi/10.1177/20563051251340862